Nov 11 (Reuters) - Shares in Evotec EVTG.DE jumped as
much as 13.3% on Monday after regulatory filings showed private
equity firm Triton had built an over 9% stake in the German drug
development company.
Evotec confirmed to Reuters that Triton now holds a 9.99%
stake in the company, making it its biggest shareholder, but
said this had no impact on its day-to-day operations.
Triton raised its stake to 3% on Nov. 4 and to 9% as of Nov.
5, regulatory filings published on Monday showed.
The shares were trading 11.6% higher at 1042 GMT. Including
the session's rise, they were down 60% since the start of 2024.
(Reporting by Isabel Demetz in Gdansk; editing by Milla Nissi)
((Isabel.Demetz@thomsonreuters.com;))